MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$36,896K
(51.41%↑ Y/Y)
Non Us
$23,216K
(73.92%↑ Y/Y)
Net loss
-$56,743K
(-11.65%↓ Y/Y)
Revenue From Contract
With Customer...
$60,112K
(59.37%↑ Y/Y)
Net loss
-$55,639K
(-12.41%↓ Y/Y)
Accrued dividends on
convertible preferred stock
$1,104K
(-16.49%↓ Y/Y)
Revenue From Contract
With Customer...
$60,112K
(59.37%↑ Y/Y)
Loss before income
taxes
-$55,094K
(-11.49%↓ Y/Y)
Provision for income taxes
$545K
(581.25%↑ Y/Y)
Product
$60,112K
Loss from operations
-$52,361K
(-11.40%↓ Y/Y)
Total other income
(expense), net
-$2,733K
(-13.21%↓ Y/Y)
Total revenues
$60,112K
(83.81%↑ Y/Y)
Interest income
$3,554K
(-2.34%↓ Y/Y)
Total costs and
expenses
$112,473K
(41.11%↑ Y/Y)
Interest expense
$4,583K
(-15.27%↓ Y/Y)
Other income
(expense), net
-$1,704K
(-164.60%↓ Y/Y)
Selling, general, and
administrative
$63,591K
(62.69%↑ Y/Y)
Research and development
$41,725K
(12.85%↑ Y/Y)
Cost of sales
$7,157K
(96.19%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
RHYTHM PHARMACEUTICALS, INC. (RYTM)
RHYTHM PHARMACEUTICALS, INC. (RYTM)